Jieyue He

Jieyue He

Auto-generated profile, based on publicly available information

Jieyue He

School of Computer Science and Engineering Key Lab of Computer Network and Information Integration MOE Southeast University 210018 Nanjing Jiangsu China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
XYXinxing Yang
Xinxing Yang
LZLbrahim Zamit
Lbrahim Zamit
YLYu Liu
Yu Liu
JHJieyue He
Jieyue He
Computational drug repositioning, which aims to find new applications for existing drugs, is gaining more attention from the pharmaceutical companies due to its low attrition rate, reduced cost, and shorter timelines for novel drug discovery. Nowadays, a growing number of researchers are utilizing the concept of recommendation systems to answer the question of drug repositioning. Nevertheless, there still lie some challenges to be addressed: 1) Learning ability deficiencies; the adopted model cannot learn a higher level of drug-disease associations from the data. 2) Data sparseness limits the generalization ability of the model. 3)Model is easy to overfit if the effect of negative samples is not taken into consideration. In this study, we propose a novel method for computational drug repositioning, Additional Neural Matrix Factorization (ANMF). The ANMF model makes use of drug-drug similarities and disease-disease similarities to enhance the representation information of drugs and diseases in order to overcome the matter of data sparsity. By means of a variant version of the autoencoder, we were able to uncover the hidden features of both drugs and diseases. The extracted hidden features will then participate in a collaborative filtering process by incorporating the Generalized Matrix Factorization (GMF) method, which will ultimately give birth to a model with a stronger learning ability. Finally, negative sampling techniques are employed to strengthen the training set in order to minimize the likelihood of model overfitting. The experimental results on the Gottlieb and Cdataset datasets show that the performance of the ANMF model outperforms state-of-the-art methods. Through performance on two real-world datasets, we believe that the proposed model will certainly play a role in answering to the major challenge in drug repositioning, which lies in predicting and choosing new therapeutic indications to prospectively test for a drug of interest.

9 December 2020 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
JHJieyue He
Jieyue He
XYXinxing Yang
Xinxing Yang
ZGZhuo Gong
Zhuo Gong
LZLbrahim Zamit
Lbrahim Zamit
Background: Drug repositioning has been an important and efficient method for discovering new uses of known drugs. Researchers have been limited to one certain type of collaborative filtering (CF) models for drug repositioning, like the neighborhood based approaches which are good at mining the local information contained in few strong drug–disease associations, or the latent factor based models which are effectively capture the global information shared by a majority of drug–disease associations. Few researchers have combined these two types of CF models to derive a hybrid model which can offer the advantages of both. Besides, the cold start problem has always been a major challenge in the field of computational drug repositioning, which restricts the inference ability of relevant models.Results: Inspired by the memory network, we propose the hybrid attentional memory network (HAMN) model, a deep architecture combining two classes of CF models in a nonlinear manner. First, the memory unit and the attention mechanism are combined to generate a neighborhood contribution representation to capture the local structure of few strong drug–disease associations. Then a variant version of the autoencoder is used to extract the latent factor of drugs and diseases to capture the overall information shared by a majority of drug–disease associations. During this process, ancillary information of drugs and diseases can help alleviate the cold start problem. Finally, in the prediction stage, the neighborhood contribution representation is coupled with the drug latent factor and disease latent factor to produce predicted values. Comprehensive experimental results on two data sets demonstrate that our proposed HAMN model outperforms other comparison models based on the AUC, AUPR and HR indicators.Conclusions: Through the performance on two drug repositioning data sets, we believe that the HAMN model proposes a new solution to improve the prediction accuracy of drug–disease associations and give pharmaceutical personnel a new perspective to develop new drugs.

12 December 2023 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
JMJiacong Mi
Jiacong Mi
YZYi Zu
Yi Zu
ZWZhuoyuan Wang
Zhuoyuan Wang
JHJieyue He
Jieyue He

31 January 2012 in Expert Systems with Applications
Verified
Journal Article
Closed access
WZWei Zhong
Wei Zhong
RCRick Chow
Rick Chow
JHJieyue He
Jieyue He

25 June 2012 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
JHJieyue He
Jieyue He
CLChaojun Li
Chaojun Li
BYBaoliu Ye
Baoliu Ye
WZWei Zhong
Wei Zhong
Most computational algorithms mainly focus on detecting highly connected subgraphs in PPI networks as protein complexes but ignore their inherent organization. Furthermore, many of these algorithms are computationally expensive. However, recent analysis indicates that experimentally detected protein complexes generally contain Core/attachment structures.

29 November 2022 in Data Mining and Knowledge Discovery
Verified
Journal Article
Closed access
PDF file
NZNaixin Zhang
Naixin Zhang
JWJinmeng Wang
Jinmeng Wang
JHJieyue He
Jieyue He